Vimarsana
Biggest News Aggregation in the World

Bioscience Managers News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Bioscience Managers. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Bioscience Managers Today - Breaking & Trending Today

Healthcare Veteran, Zach Henderson to lead Global Kinetics as CEO - Vimarsana News

Healthcare Veteran, Zach Henderson to lead Global Kinetics as CEO

CHARLOTTE, N.C. and MELBOURNE, Australia, May 3, 2023 /PRNewswire/ -- Global Kinetics, the global leader in digital health solutions for neurological conditions, today announced the appointment

Pharmaxis Ltd appoints senior global pharma executive Dr Simon Green as a non-executive director - Vimarsana News

Pharmaxis Ltd appoints senior global pharma executive Dr Simon Green as a non-executive director

Pharmaxis Ltd (ASX:PXS, OTC:PMXSF) has appointed experienced senior global pharma executive Dr Simon Green to the Board of Directors as an independent...

BioScience Managers Announces the Appointment of Dr. David Atkins as Managing Partner to Continue its Growth in Digital Health - Vimarsana News

BioScience Managers Announces the Appointment of Dr. David Atkins as Managing Partner to Continue its Growth in Digital Health

/PRNewswire/ -- BioScience Managers, the international healthcare investment firm, is pleased to announce the appointment of David Atkins MBA PhD in the role...

Humanetix partners with BioScience Managers - Australian Ageing Agenda - Vimarsana News

Humanetix partners with BioScience Managers - Australian Ageing Agenda

Humanetix and BioScience Managers have teamed up to launch point-of-care documentation platform ACE globally.

Australian taxpayer-funded fund invested millions in struggling NZ exoskeleton company - Vimarsana News

Australian taxpayer-funded fund invested millions in struggling NZ exoskeleton company

An Australian government fund meant to support local biomedical development spent millions to buy a close-to-insolvent New Zealand-based exoskeleton company that has almost no operations in Australia.

Source: smh.com.au